Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Guyuchun Biotechnology is a specialized biotechnology company headquartered in Jinan, China, dedicated to the development and manufacturing of high-quality biological reagents. The company utilizes advanced recombinant protein expression platforms, including bacterial, yeast, and mammalian cell systems, to produce a wide array of antigens, antibodies, and enzymes. Their core business focuses on providing essential components for veterinary diagnostic kits and vaccine research, particularly for significant animal diseases such as African Swine Fever and Porcine Reproductive and Respiratory Syndrome. In addition to animal health, Guyuchun Biotechnology offers molecular biology enzymes and customized protein services to support life science research and industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Guyuchun Biotechnology.